NCT02187302 · Interventional trial
CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)
Overall registry status Completed
Phase 2
Conditions Metastatic Renal Cell Carcinoma
Delaware Valley sites
- MD Anderson Cooper Cancer Institute · Voorhees Township, NJ · Camden County
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory